On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...
As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...
Shares of Aurora Cannabis Inc. ACB shed 4.68% to $6.31 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.41% to ...
Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...
Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.
Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The business’s 50-day moving average is $4.35 and its 200 day moving average is $5.16.
Aurora Cannabis Inc. (ACB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results